Edges in Network
| Network | GSE12093_egf1520 - GSE12093 - SiGN-BN HC+Bootstrap |
| Network Description | The 76-gene Signature Defines High-Risk Patients that Benefit from Adjuvant Tamoxifen Therapy |
| Node | SLC16A6 |
| Upstream (Parents) |
|---|
| (<<) CCND1 → SLC16A6 |
| (<<) CHODL → SLC16A6 |
| (<<) CSTA → SLC16A6 |
| (<<) CYP1B1 → SLC16A6 |
| (<<) GDF15 → SLC16A6 |
| (<<) GNRH2 → SLC16A6 |
| (<<) IER3 → SLC16A6 |
| (<<) MLX → SLC16A6 |
| (<<) PRKACB → SLC16A6 |
| (<<) PRKCB → SLC16A6 |
| (<<) RARA → SLC16A6 |
| (<<) ROCK2 → SLC16A6 |
| (<<) RPS6KB1 → SLC16A6 |
| (<<) SCG5 → SLC16A6 |
| (<<) SERPINB1 → SLC16A6 |
| (<<) SMAD5 → SLC16A6 |
| (<<) UBE2E3 → SLC16A6 |
| (<<) WNT3 → SLC16A6 |
| (<<) YWHAH → SLC16A6 |
| Downstream (Children) |
|---|
| SLC16A6 → CBS (>>) |
| SLC16A6 → CKB (>>) |
| SLC16A6 → DYRK1A (>>) |
| SLC16A6 → FGFR3 (>>) |
| SLC16A6 → FLJ22184 (>>) |
| SLC16A6 → GNB1L (>>) |
| SLC16A6 → HKDC1 (>>) |
| SLC16A6 → HSD17B2 (>>) |
| SLC16A6 → OGFR (>>) |
| SLC16A6 → ST3GAL6 (>>) |
